Le Lézard
Classified in: Health
Subjects: CHI, RCL, PSF, CFG

Information Update - RW Consumer Products Ltd. voluntarily recalls all lots of "Gripe Water - Alcohol And Preservative Free" because of microbial contamination


OTTAWA, Sept. 21, 2019 /CNW/ - Health Canada is advising Canadians that RW Consumer Products Ltd. is recalling all lots of the product "Gripe Water ? Alcohol And Preservative Free" (Natural Product Number [NPN] 80080669), sold under various brand names, because company testing showed microbial contamination. These products have been sold at retailers across Canada.

These products are marketed as a "gentle antacid for quick relief of baby's minor stomach upsets such as colic, cramps, gas, sour stomach, and hiccups especially during teething."

Ingesting a contaminated product may pose serious health risks. Microbial contamination typically increases the risk of infections, particularly within a vulnerable subpopulation such as infants. Infants have developing immune systems and, as a result, may be more susceptible to the effects of an infection. Symptoms of a microbial infection in infants may include vomiting and watery diarrhea, fever and abdominal pain.

Health Canada will monitor the company's recall and inform Canadians if new safety information becomes available.

Who is affected
Anyone who has bought or used these gripe water products for their baby.

Affected products
The recalled "Gripe Water ? Alcohol And Preservative Free" products are labelled with the NPN 80080669 and are sold under the following brand names:

Atoma
Baby's Choice
Be Better
Equate
Life Brand
Personnelle
Pharmasave
Teddy's Choice
Western Family

What consumers should do

Également disponible en français

SOURCE Health Canada


These press releases may also interest you

at 05:25
PureTech Health plc ("PureTech" or the "Company") today announces its results for the year ended December 31, 2023, as well as its cash balance as of the first quarter ended March 31, 2024. The following information represents select highlights from...

at 05:11
Hyundai Bioscience announced on April 25th that its clinical development plan of oral "Niclosamide Metabolic Anticancer Drug" targeting cancer patients with intractable cancer caused by p53 gene mutations. Mutations in the p53 gene occur in almost...

at 04:31
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CHINA, HONG KONG, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR...

at 04:30
The Balance RehabClinic, renowned for its luxury mental health and addiction services, proudly announces its expansion into The Balance Healthcare Group: a collection of premium mental health solutions tailored for affluent individuals. These new...

at 03:47
Zest Dental Solutions, a global leader in innovative dental solutions proudly announces a strategic partnership with The Pathway. Founded by Justin Moody, DDS and based in Arizona, The Pathway is a continuing education program that teaches dentists...

at 03:34
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that its selective cathepsin K inhibitor, MIV-711, has been granted Rare Pediatric Disease...



News published on and distributed by: